Login / Signup

Caspofungin Population Pharmacokinetic Analysis in Plasma and Peritoneal Fluid in Septic Patients with Intra-Abdominal Infections: A Prospective Cohort Study.

Nicolas GarbezLitaty C MbatchiSteven C WallisLaurent MullerJeffrey LipmanJason Alexander RobertsJean-Yves LefrantClaire Roger
Published in: Clinical pharmacokinetics (2021)
There is moderate penetration of caspofungin into the peritoneal cavity (33%). For empirical treatment, a dose escalation of 100 mg loading dose on the first day is suggested for higher FFM to ensure adequate concentrations into the abdominal cavity for the most susceptible candida species.
Keyphrases
  • acute kidney injury
  • candida albicans
  • high intensity
  • clinical trial
  • escherichia coli
  • staphylococcus aureus
  • pseudomonas aeruginosa